Three phenotypes of obstructive lung disease in the elderly
1Department of Pulmonary and Critical Care Medicine & Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Summary
This study identified three distinct phenotypes in elderly individuals with obstructive lung disease (OLD), characterized by varying degrees of airflow obstruction and bronchodilator reversibility. Further research is needed to understand the clinical implications of these obstructive lung disease phenotypes.
Area of Science:
- Pulmonology
- Geriatric Medicine
- Medical Imaging
Background:
- Obstructive lung disease (OLD) affects elderly individuals, but distinct phenotypes require classification for targeted management.
- Understanding phenotypic variations in elderly patients with OLD is crucial for improving clinical outcomes.
Purpose of the Study:
- To classify the distinct phenotypes present in elderly subjects diagnosed with obstructive lung disease (OLD).
Main Methods:
- Analysis of 191 elderly subjects (≥ 60 years) with chronic respiratory symptoms and obstructive spirometry or bronchial hyperresponsiveness.
- Factor and cluster analyses were performed using inspiratory capacity to total lung capacity ratio, St George's Respiratory Questionnaire score, lung density on CT, and post-bronchodilator FEV1 changes.
Main Results:
- Three distinct phenotypes of obstructive lung disease were identified in the elderly cohort.
- Cluster 1: Moderate to severe airflow obstruction with bronchodilator reversibility.
- Cluster 2: Moderate airflow obstruction without bronchodilator reversibility.
- Cluster 3: Severe airflow obstruction without bronchodilator reversibility.
Conclusions:
- Three clinically relevant phenotypes were identified in elderly patients with obstructive lung disease (OLD).
- Further investigation is warranted to elucidate the clinical significance and prognostic value of each identified phenotype.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: